DrugsControl Media Services

News Detail

Breast cancer drug letrozole linked to brain malfunction (26-12-2018)

Toronto, 26 Dec 2018: A study in nonhuman primates by researchers at the University of Massachusetts and the University of Maryland School of Medicine has shown that the breast cancer drug letrozole has adverse effects on the brain. Letrozole is an aromatase inhibitor (AI) t......
View Details

Source : Genetic Engineering & Biotechnology News

Related News